Added value of PCR-testing for confirmation of invasive meningococcal disease in England

Ellen Heinsbroek1, Shamez Ladhani, Steve Gray

  • 1European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; Immunisation, Hepatitis & Blood Safety Department, Public Health England, London, United Kingdom.

Abstract

Insights

Polymerase chain reaction (PCR) testing confirms over half of invasive meningococcal disease (IMD) cases, significantly improving national surveillance. This molecular diagnostic method enhances case ascertainment beyond traditional blood cultures.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • National guidelines in England mandate blood culture and PCR testing for suspected invasive meningococcal disease (IMD).
  • The Meningococcal Reference Unit (MRU) offers national services for IMD confirmation and PCR testing.
  • A population-level assessment was conducted to evaluate the added value of PCR testing for IMD.

Purpose of the Study:

  • To assess the added value of PCR testing in augmenting traditional culture confirmation for invasive meningococcal disease (IMD).
  • To evaluate the contribution of PCR testing to national surveillance of IMD.

Main Methods:

  • Analysis of all PCR samples and invasive meningococcal isolates submitted to the MRU during 2009-2010.
  • Assumption that all patients with PCR samples also had blood cultures performed, with positive cultures referred to MRU.
  • Case ascertainment was used to confirm the assertion of concurrent blood culture performance.

Main Results:

  • A total of 25,379 specimens from 22,039 patients were tested via PCR, with 1492 (6.8%) testing positive.
  • MRU received 825 invasive meningococcal isolates; 393 were confirmed by both PCR and culture.
  • Out of 1924 reported IMD cases, 1099 (57.1%) were confirmed by PCR only, 432 (22.5%) by culture only, and 393 (20.4%) by both.

Conclusions:

  • PCR testing alone confirmed over half of all invasive meningococcal disease (IMD) cases.
  • The national PCR testing service ensures high case ascertainment for IMD surveillance.
  • PCR testing significantly enhances the detection of IMD compared to culture alone.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...